1.Systemamtic Evaluation of Clopidogrel Combined with Atorvastatin in the Treatment of Ischemic Cardiovascular Disesase
China Pharmacy 2005;0(24):-
OBJECTIVE:To investigate the effects of clopidogrel plus atorvastatin on ischemic cardiovascular diseases and to explore the clinical significance of drug interactions.METHODS:Literatures were retreived from EMBase,PubMed,Cochrane Library and CNKI with clopidogrel,atorvastatin,clinical trial as
4.The regulatory role of autophagy in tumor process.
Acta Pharmaceutica Sinica 2016;51(1):23-28
Autophagy is a classical regulatory mechanism of energy metabolism and self-update system in the maintenance of the intracellular homeostasis and cell development. Autophagy has been recently found to play a role in tumor development. Autophagy regulates tumor formation, proliferation, metastasis, and metabolism. At the same time, the anticancer drugs formed with autophagic mediators have been used in the treatment, which suggested that improving autophagy activity to inhibit tumor has become a new way for cancer treatment of cancer patients. This article gives an overview of the regulatory mechanism of autophagy, the relationship between autophagy and tumor, and tumor therapy by targeting autophagy.
Antineoplastic Agents
;
Autophagy
;
Humans
;
Neoplasms
;
physiopathology
5.Phosphoprotein EBP50 suppresses proliferation of breast cancer by inhibiting activity of ERK1/2 in MCF-7 cell line
Hong LIU ; Yan MA ; Rongguang SHAO
Chinese Pharmacological Bulletin 2015;(1):55-59
Aim To investigate the relationship be-tween phosphoprotein EBP50 and the proliferation of breast cancer in MCF-7 cells. Methods The quali-fied recombinant plasmid sh-EBP50-pGPU6/Neo was transfected into MCF-7 cells with EBP50 knocking down. The expression of EBP50, c-myc, p-ERK1/2, and ERK1/2 was detected by Western blot. The prolif-eration ability of cells was detected by sulforhodamine B assay. Results The EBP50 knocking down plasmid was constructed successfully. MCF-7 cells with EBP50 knocking down had been established successfully. Knocking down of EBP50 increased the proliferation of MCF-7 significantly, and partially augmented the ex-pression of c-myc and phosphorylation of ERK1/2 . However, knocking down of EBP50 did not impact the expression of ERK1/2 . Conclusion EBP50 suppres-ses the proliferation of breast cancer cell through inhib-iting the activity of ERK1/2 in MCF-7 cell line.
6.Treatment of dyslipidemia in the elderly
Hong SHAO ; Liquan CHEN ; Jun XU
Journal of Geriatric Cardiology 2011;08(1):55-64
Dyslipidemia is a well-established risk factor for atherosclerosis. Treating dyslipidemia in elderly patients requires specific knowledge and understanding of common dyslipidemias and the relative safety of various pharmacologic agents in the presence of possible multiple comorbidities. Lifestyle modification remains the first step in the treatment of dyslipidemia; however, it can be difficult to sustain and achieve acceptable compliance in the elderly and it is best used in combination with drug therapy. Statins are widely accepted as the first-line therapy. Several recent studies have demonstrated that statins are safe and effective in the elderly. However, it is important to note that there is very limited data regarding the effects of dyslipidemia treatment on morbidity and mortality in patients over 85 years of age. In summary, the clinicians must recognize that the presence of dyslipidemia in the elderly poses substantial risk of coronary events and stroke. The available evidence has demonstrated that in most elderly patients who are at increased risk for cardiovascular morbidity and mortality, treatment of dyslipidemia with appropriate therapy reduces the risk, and when used carefully with close monitoring for safety, the treatment is generally well tolerated. With increasing life expectancy, it is critical for physicians to recognize the importance of detection and treatment of dyslipidemia in the elderly.
7.Application of Leucocyte Adherence Inhibition Test in Determining Immunological Activity of Ribonucleic Acid
Wang CAN ; Shao HONG ; Chen GANG
China Pharmacist 2015;(11):1848-1850
Objective:To establish a method for determining the immunological activity of ribonucleic acid. Methods: Leucocyte adherence inhibition test ( LAI) was applied, and the important parameters of LAI including the mouse strain, drug concentration, treatment time, content of buffer solution and cell density were researched. The immunological activity of RNAⅠ, Ⅱand Ⅲ was re-spectively determined by the method. Results:Stable and reliable parameters were obtained: the sample concentration was 10 mg· ml-1 , the treatment time was 2 hours, Ca2+ and Mg2+ were necessary for the buffer solution, and the cell density was about 4 × 107 cell·ml-1 . The strain of mouse showed no effect on the results. As a result, the determination method for immunological activity was established. Using the method, the immunological activity of RNA Ⅰ,Ⅱand Ⅲ was determined 3 times, and the results met the re-quirements with RSD below 20%. Conclusion:The method is suitable for determining the immunological activity of RNA.
8.Currenr Status of Study on the Human Health Effects of Inhalable Particulates
Hong LI ; Fangang ZENG ; Longyi SHAO
Journal of Environment and Health 1993;0(01):-
The significance of the study on the human healht effects of inhalable particulates(PM10) was pointed out,specific properties of inhalable particulates,such as chemical components,aerodynamic behavior and transference in respiratory tract,were then presented.The serious harm of inhalable particulates on human health were summarized based on research results of epidemiological study,animal toxicological study and clinical study,and research emphasis to which should pay more attention in the future study of this aspects was also suggested.
9.Investigation of Drinking Water Quality in Rural Areas in Jiading,Shanghai in 2006
Hong YUAN ; Jiadi TAN ; Yueqin SHAO
Journal of Environment and Health 1989;0(06):-
Objective To understand the drinking water quality in the rural areas in Jiading, Shanghai. Methods In September, 2006, the drinking water samples from water plants and tap water were collected, then the water quality was analyzed and assessed according to the related standards and regulations. Results 84.56% of the rural population drank the surface water, 15.44% drank the ground water. Among 99.85% of the centralized water supply systems, the drinking water (surface water) was treated; among 0.15%, the drinking water (ground water) was only treated by decreasing iron and manganese. Source water and treated water quality had been greatly improved. Conclusion Intensive management of drinking water is very important to ensure the drinking water quality in the rural areas.
10.The clinical observation of Chinese medicine on TPOAb, TGAb of the patients with Hashimoto's thyroiditis
Ming DU ; Hong WANG ; Yingxin SHAO
International Journal of Traditional Chinese Medicine 2014;(5):419-421
Objective To observe the effect of the Chinese medicine on the patients’ thyroid autoantibodies TPOAb and TGAb of Hashimoto's thyroiditis. Methods 100 cases of Hashimoto's thyroiditis were randomly divided into group A and group B, with 50 cases in each group. Group A was given levothyroxine sodium(L-T4) to maintain thyroid function(FT3,FT4,TSH)in the normal range, at the same time Chinese medicines of soothing liver and strengthening spleen, nourishing the liver and kidney, activating blood and removing blood stasis were additionally added;while group B was taken L-T4 to maintain the thyroid function in the normal range. The levels of TPOAb, TGAb were determined before and after treatment in both groups. Results After the treatment, the level of TGAb and TPOAb[respectively(106.3±29.5)IU/ml,(871.5± 209.3)IU/ml] in group A were decreased compared with their previous level [respectively(385.5±76.6)IU/ml, (1621.5±399.2)IU/ml], the difference was statistically significant(t were 48.2、10.6,P<0.01). The level of TGAb and TPOAb [respectively(437.6±135.4)IU/ml,(1798.6±434.6)IU/ml] in group B were slightly increase than their previous level[respectively(383.9±105.8)IU/ml,(1633.2±396.5)IU/ml], with no significant difference. The levels of TPOAb and TGAb in group A had significant difference than those in group B after the treatment(t were 22.3、19.6,P<0.01). Conclusion TCM combined with L-T4 can reduce the level of thyroid autoantibodies of TPOAb and TGAb-in patients.